Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - SMITH & NEPHEW PLC (SN.-LN)11$25  View Abstract
19-Apr-14Reuters Investment ProfileN/ASmith & Nephew PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
9-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Smith & Nephew PLC42$75  View Abstract
8-Apr-14MarketLine (a Datamonitor Company)MarketLineSmith & Nephew plc47$175  View Abstract
4-Apr-14GlobalDataGlobalDataSmith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review67$125  View Abstract
14-Mar-14Wall Street Transcript ,TheThe Wall St TranscriptContinued Improvement in Medical Device End Markets for 20144$50  View Abstract
11-Mar-14Streetwise ReportsN/APaul Adams: Investor-Friendly Australian Projects Around the World8$80.50  View Abstract

Independent Reports (Showing 1 to 7 of 7)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - SMITH & NEPHEW PLC (SN.-LN)11$25View Abstract
19-Apr-14Reuters Investment ProfileN/ASmith & Nephew PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
9-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Smith & Nephew PLC42$75View Abstract
8-Apr-14MarketLine (a Datamonitor Company)MarketLineSmith & Nephew plc47$175View Abstract
4-Apr-14GlobalDataGlobalDataSmith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review67$125View Abstract
14-Mar-14Wall Street Transcript ,TheThe Wall St TranscriptContinued Improvement in Medical Device End Markets for 20144$50View Abstract
11-Mar-14Streetwise ReportsN/APaul Adams: Investor-Friendly Australian Projects Around the World8$80.50View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.